Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             227 results found
no title author magazine year volume issue page(s) type
1 104 Activity against human cytomegalovirus, cytotoxicity and mode of action of a non-nucleoside pyrrolo[2,3-d]pyrimidine 1994
 23 S p. 91-
1 p.
 article
2 112 Activity of azidothymidine (AZT) in combination with several antiviral nucleosides against varicella zoster virus (VZV) replication In vitro 1994
 23 S p. 95-
1 p.
 article
3 69 Activity of famciclovir and penciclovir in HSV-infected animals: A review 1994
 23 S p. 72-
1 p.
 article
4 70 A double-blind, placebo (PLB)-controlled trial of the effect of chronically administered oral famciclovir (FCV; BRL 42810) on sperm production in men with recurrent genital herpes (RGH) infection 1994
 23 S p. 72-
1 p.
 article
5 173 An economical MTT-based in vitro assay system for bovine viral diarrhea virus (BVDV): A pestivirus in the family of flaviviridae 1994
 23 S p. 128-
1 p.
 article
6 137 Animal models of herpes family viral retinitis 1994
 23 S p. 108-
1 p.
 article
7 130 Antiherpes effect of dextran sulphate combined with acyclovir in vitro and in vivo 1994
 23 S p. 104-
1 p.
 article
8 106 Anti-human cytomegalovirus (HCMV) activity of sulfonated anthraquinones 1994
 23 S p. 92-
1 p.
 article
9 184 Anti-influenza virus activity of 4-guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid in vitro 1994
 23 S p. 133-
1 p.
 article
10 37 Antiretroviral activity and selective cytotoxicity of lithium gamma-linolenic acid (LiGLA) 1994
 23 S p. 55-
1 p.
 article
11 36 Antiretroviral activity of N-α-acetyl-nona-D arginine amide acetate (ALX40-4C) 1994
 23 S p. 54-
1 p.
 article
12 56 Antiretroviral efficacy and pharmacokinetics of ester prodrugs of 9-(2-phosphonylmethoxy-ethyl) adenine (PMEA) 1994
 23 S p. 64-
1 p.
 article
13 180 Antisense inhibition of respiratory syncytial virus replication 1994
 23 S p. 131-
1 p.
 article
14 66 Antisense oligonucleotides against BZLF-1 inhibit induction of the productive replication of EBV 1994
 23 S p. 70-
1 p.
 article
15 164 Antiviral action of glutathione: Study on the mechanism 1994
 23 S p. 123-
1 p.
 article
16 91 Antiviral activity and mode of action of a sulfated galactan from Pterocladia capillaceae 1994
 23 S p. 84-
1 p.
 article
17 177 Antiviral activity of 1-methylascorbigen against bynyaviral infections (in experimental) 1994
 23 S p. 130-
1 p.
 article
18 188 Antiviral activity of mizoribine (4-carbamyl-1-B-D-ribofuranosylimidazolium-5-olate) against ortho- and paramyxoviruses 1994
 23 S p. 135-
1 p.
 article
19 82 Antiviral activity of penciclovir, a novel antiherpesvirus compound, against duck hepatitis B virus in vitro 1994
 23 S p. 79-
1 p.
 article
20 172 Antiviral activity of proteolytic inhibitor ambenum (para-aminomethylbenzoic acid). V.P. Lozitsky, A.S. 1994
 23 S p. 127-
1 p.
 article
21 122 Antiviral activity of triciribine and triciribine monophosphate against human herpesvirus type 6 1994
 23 S p. 100-
1 p.
 article
22 163 Antiviral drug izatizon restores interferon action. The enlargement of interferon antiviral activity spectrum 1994
 23 S p. 123-
1 p.
 article
23 199 Antiviral effect of BC30 in experimental influenza virus infection in white mice 1994
 23 S p. 141-
1 p.
 article
24 11 Antiviral properties of BMS 182,193, an aminoalcohol inhibitor of HIV protease 1994
 23 S p. 41-
1 p.
 article
25 29 Antiviral properties of BMS 182,193, an aminoalcohol inhibitor of HIV protease 1994
 23 S p. 51-
1 p.
 article
26 Antiviral research branch enteric diseases branch national institute of allergy and infections diseases national institutes of health 1994
 23 S p. 148-149
2 p.
 article
27 86 A phase I/II open-label study to assess the safety, pharmacokinetic profile, and preliminary antiviral effects of ost-577 (a human anti-hepatitis b surface antigen monoclonal antibody) administered to patients who are persistently hepatitis b antigen seropositive 1994
 23 S p. 81-
1 p.
 article
28 196 Aprotinin treatment of influenza b virus bronchopneumonia of mice 1994
 23 S p. 139-
1 p.
 article
29 166 A rapid and high capacity In vitro antiviral assay for hepatitis B virus using quantitative polymerase chain reaction (PCR) 1994
 23 S p. 124-
1 p.
 article
30 60 A stromal cell line from LP-BM5 infected long-termm bone marrow cell cultures (LTBMC) inhibits hematopoiesis In Vitro 1994
 23 S p. 66-
1 p.
 article
31 3 A structural model for HIV-1 integrase 1994
 23 S p. 36-
1 p.
 article
32 Author index 1994
 23 S p. 145-147
3 p.
 article
33 79 A variant of echovirus 12 that requires the selective antiviral inhibitor rhodanine for replication 1994
 23 S p. 78-
1 p.
 article
34 182 A wide spectrum of antiviral activity of a new syntetic inhibitor of proteolysis 1994
 23 S p. 132-
1 p.
 article
35 143b Antiviral drug resistance mutations in HIV-1 reverse transcriptase occur in specific RNA structural regions 1994
 23 S p. 111-
1 p.
 article
36 50 Biochemical analysis of human immunodeficiency virus type-1 reverse transcriptase with mutations at methione 184 in the highly conserved YMDD region: Mechanism for 1-β-L nucleoside drug resistance 1994
 23 S p. 61-
1 p.
 article
37 38 Biological and biochemical anti-HIV activity of a phosphorothioate G-quartet (TTGGGGTT) 1994
 23 S p. 55-
1 p.
 article
38 176 Bone marrow mononuclear cells producing IL-1 and IL-2 inhibited by HBV in vitro and in vivo 1994
 23 S p. 129-
1 p.
 article
39 147 Boron modified peptide: A novel dissociative inhibitor of HIV-1 protease 1994
 23 S p. 114-
1 p.
 article
40 153 Brain delivery of 2′-F-ara-ddl by utilizing xanthine oxidase biotransformation system 1994
 23 S p. 117-
1 p.
 article
41 90 Carboxy-terminal peptidomimetics of the herpes simplex virus ribonucleotide reductase small subunit inhibit viral replication and potentiate the antiviral activity of acyclovir 1994
 23 S p. 84-
1 p.
 article
42 15 Clinical trials of (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (HPMPC) 1994
 23 S p. 43-
1 p.
 article
43 194 Combinated antiviral effect of some bacterial and synthetic inhibitors 1994
 23 S p. 138-
1 p.
 article
44 192 Combination effects of picornavirus replication inhibitors 1994
 23 S p. 137-
1 p.
 article
45 197 Combined effect of an antioxidative agent (ionol) and rimantadine on experimental influenza virus A(H3N2) infection in mice 1994
 23 S p. 140-
1 p.
 article
46 121 Comparative activity of penciclovir and acyclovir against epstein-barr virus 1994
 23 S p. 99-
1 p.
 article
47 68 Comparative activity of penciclovir and acyclovir against herpes simplex virus type 2 in cell culture 1994
 23 S p. 71-
1 p.
 article
48 111 Comparative activity of selected antiviral compounds on In vitro replication of varicella zoster virus clinical strains 1994
 23 S p. 94-
1 p.
 article
49 93 Comparative antivirial activity of compounds against thymidine-kinase deficient acyclovir resistant mutants of herpes simplex virus type 1 1994
 23 S p. 85-
1 p.
 article
50 39 Comparative biological and biochemical evaluation of a diverse group of nonnucleoside reverse transcriptase inhibitors 1994
 23 S p. 56-
1 p.
 article
51 12 Comparison of anti-HSV activity and metabolism of acyclic nucleotide analogs 1994
 23 S p. 41-
1 p.
 article
52 42 Comparison of antiretroviral drug combinations in a murine leukemia virus (MuLV) model 1994
 23 S p. 57-
1 p.
 article
53 99 Comparison of penciclovir with acyclovir for treatment of severe herpes simplex virus infections of mice 1994
 23 S p. 88-
1 p.
 article
54 113 Comparison of selective indexes of anti-varicella-zoster virus activity of nucleoside analogues 1994
 23 S p. 95-
1 p.
 article
55 47 Comparison of the conformations of the 5′-triphosphates of zidovudine® (AZT) and thymidine bound to HIV-1 reverse transcriptase 1994
 23 S p. 60-
1 p.
 article
56 72 Comparison of topical capsaicin and parenteral acyclovir in the treatment of primary genital herpes: Effect of treatment on the subsequent development of recurrent disease 1994
 23 S p. 73-
1 p.
 article
57 Conference banquet 1994
 23 S p. 6-
1 p.
 article
58 Conference committees 1994
 23 S p. 3-4
2 p.
 article
59 Corporate sponsors 1994
 23 S p. 5-6
2 p.
 article
60 108 Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits HCMV at or near the stage of DNA replication 1994
 23 S p. 93-
1 p.
 article
61 135 Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses 1994
 23 S p. 107-
1 p.
 article
62 136 Cyclocreatine improves the structural integrity of the retina in human cytomegalovirus-induced chorioretinitis in the rabbit model 1994
 23 S p. 107-
1 p.
 article
63 22 Cytosolic delivery of anti-hiv nucleoside monophosphates having enzyme-labile transient phosphate protecting groups 1994
 23 S p. 47-
1 p.
 article
64 179 Determination of functional domains in the influenza virus polymerase through site-directed mutagenesis and transient expression 1994
 23 S p. 131-
1 p.
 article
65 Developmental therapeutics branch division of AIDS national institute of allergy and infectious diseases national institutes of health 1994
 23 S p. 149-150
2 p.
 article
66 134 Development of a guinea pig model for determining the pharmacokinetics of antiviral agents 1994
 23 S p. 106-
1 p.
 article
67 150 Development of an In Vivo model of HIV latency and activation 1994
 23 S p. 115-
1 p.
 article
68 85 Development of (−)-β-D-2,6-diaminopurine dioxolane as a potential antiviral agent 1994
 23 S p. 81-
1 p.
 article
69 34 Didanosine (DDI) and zidovudine (AZT) sensitivities of HIV-1 strains isolated from DDI-treated patients, and tested in a heLa-CD4 immunofluorescence focus assay (IFFA) 1994
 23 S p. 53-
1 p.
 article
70 146 Drug-induced cell mediated mechanism leading to resistance of HIV to AZT 1994
 23 S p. 113-
1 p.
 article
71 145 Drug-resistant HIV-1 mutants may undergo further mutations in their reverse transcriptase (RT) under continuous pressure of HIV-1-specific RT inhibitors 1994
 23 S p. 113-
1 p.
 article
72 Editorial Board 1994
 23 S p. ii-
1 p.
 article
73 61 Effect of antiviral nucleoside analogs on human polymerases and mitochondrial DNA synthesis 1994
 23 S p. 67-
1 p.
 article
74 165 Effect of fialuridine (FIAU) on the in vitro replication of mitochondrial DNA in human T cells and in human hepatoblastoma cells 1994
 23 S p. 124-
1 p.
 article
75 97 Effect of human recombinant and recombinant hybrid alpha-interferons on the replication of herpes simplex virus type 1 in human fibroblast and neuroblastoma cells 1994
 23 S p. 87-
1 p.
 article
76 178 Effect of ribavirin on SSPE virus infection in hamsters 1994
 23 S p. 130-
1 p.
 article
77 131 2Effect of the gamma interferon (r) alone and in combination 2on O 2the replication of the Human cytomegalovirus 1994
 23 S p. 104-
1 p.
 article
78 96 Effect of zn-complexes on HSV-2 infection in vitro 1994
 23 S p. 87-
1 p.
 article
79 140 Effects of combinations of HIV-1 specific RT inhibitors with complementary resistance profiles on the time and type of drug-resistant HIV-1 development 1994
 23 S p. 109-
1 p.
 article
80 40 Effects of HIV-inhibitory compounds on the production of virus from chronically and latently infected cell lines 1994
 23 S p. 56-
1 p.
 article
81 84 Effects of IFNα on HBV gene expression in transgenic mice 1994
 23 S p. 80-
1 p.
 article
82 71 Efficacy of famciclovir on herpes zoster rash resolution and post-herpetic neuralgia 1994
 23 S p. 73-
1 p.
 article
83 9 Enantiomeric DDC derivatives are potent inhibitors of HIV replication in cell cultures 1994
 23 S p. 39-
1 p.
 article
84 101 Evaluation of retinal toxicity and efficacy of a phosphorothioate antisense against herpes retinitis in a rabbit model 1994
 23 S p. 89-
1 p.
 article
85 17 Evaluation of retinal toxicity of the anti-CMV compound 2-amino-7-[(1,3-dihydroxy-2-propoxy) methyl] purine 1994
 23 S p. 44-
1 p.
 article
86 120 Expression and functional characterization of epstein-barr virus DNA polymerase in insect cells infected with a recombinant baculovirus 1994
 23 S p. 99-
1 p.
 article
87 148 Factors other than reverse transcriptase contribute to resistance of feline immunodeficiency virus to reverse transcriptase-targeted antivirals 1994
 23 S p. 114-
1 p.
 article
88 118 Famciclovir: Confirmed efficacy of 250mg t.i.d for the treatment of herpes zoster (HZ) infection. M. 1994
 23 S p. 98-
1 p.
 article
89 119 Famciclovir in the treatment of herpes zoster (HZ) infection 1994
 23 S p. 98-
1 p.
 article
90 185 First phase of clinical trials new antiviral drug-viramid 1994
 23 S p. 134-
1 p.
 article
91 43 Ganciclovir does not antagonize the anti-human immunodeficiency virus activity of AZT in A3.01 cells in vitro 1994
 23 S p. 58-
1 p.
 article
92 117 GR95168X (chiral carbocyclic BVdU) is highly effective against simian varicella virus infections of African green monkeys 1994
 23 S p. 97-
1 p.
 article
93 204 Guinea pig as a model for study of marburg virus interraction with mononuclear phagocytes 1994
 23 S p. 143-
1 p.
 article
94 89 5-Heteroaromatic substituted 2′-deoxyuridines as anti-HSV-1 agents: Synthesis, antiviral activity and structure-activity relationship 1994
 23 S p. 83-
1 p.
 article
95 116 Highly bioavailable prodrugs of the potent anti-varicella zoster virus agent, 1-(β-D-arabinofuranosyl)-5-prop-1-ynyluracil (882C87) 1994
 23 S p. 97-
1 p.
 article
96 152 HIV-infected Hu-PBMC-SCID mice as a model for antiviral drug development 1994
 23 S p. 116-
1 p.
 article
97 53 Hydroxyurea inhibits HIV-1 replication by inducing low dNTP levels. A cellular enzyme as a target to inhibit HIV-1 1994
 23 S p. 63-
1 p.
 article
98 186 Identification of a novel class of oligonucleotide inhibitors of the influenza viral polymerase 1994
 23 S p. 134-
1 p.
 article
99 144 Identification of distinct subgroups of nonnucleoside reverse transcriptase inhibitors defined by cross-resistance phenotypes of drug-resistant virus isolates 1994
 23 S p. 112-
1 p.
 article
100 67 Identification of the specific serine residue at the active site of the herpes simplex virus type 1 protease 1994
 23 S p. 71-
1 p.
 article
101 98 Immunoprophylactic strategies for prevention of genital herpes simplex virus infections 1994
 23 S p. 88-
1 p.
 article
102 74 Increased bioavailability of acyclovir from oral valaciclovir in healthy volunteers 1994
 23 S p. 74-
1 p.
 article
103 83 Inhibition of duck hepatitis B virus DNA polymerase by the triphosphate of fialuridine 1994
 23 S p. 80-
1 p.
 article
104 170 Inhibition of duck hepatitis B virus replication by N-(phosphonoacetyl)-L-aspartate (PALA; USNUS-08-0) In vitro 1994
 23 S p. 126-
1 p.
 article
105 167 Inhibition of HBV polymerase by nucleotide analogs: Differential activity of enantiomers 1994
 23 S p. 125-
1 p.
 article
106 80 Inhibition of Hepatitis B virus replication in vitro by Antisense oligonucleotides 1994
 23 S p. 78-
1 p.
 article
107 92 Inhibition of herpes simplex type 1 by meliacine, a peptide of plant origin 1994
 23 S p. 85-
1 p.
 article
108 102 Inhibition of herpes simplex virus type 1 replication by a hybrid E. coli heat-labile enterotoxin B subunit 1994
 23 S p. 90-
1 p.
 article
109 51 Inhibition of HIV-1 replication by SDZ NIM 811, a non-immunosuppressive cyclosporin a analog: Mode of action studies 1994
 23 S p. 62-
1 p.
 article
110 190 Inhibition of influenza virus reproduction by combined preparations of medicinal plants 1994
 23 S p. 136-
1 p.
 article
111 183 Inhibition of respiratory syncytial virus replication In vitro by N-butyldeoxynojirimycin (NB-DNJ/SC-48334) 1994
 23 S p. 133-
1 p.
 article
112 200 Inhibition of virus infections of mice by the combination of aerosolized MnSOD and ribavirin 1994
 23 S p. 141-
1 p.
 article
113 Introduction to sponsors 1994
 23 S p. 5-
1 p.
 article
114 95In vitro activity of the herpes simplex virus type 1 and cytomegalovirus proteases with peptide substrates 1994
 23 S p. 86-
1 p.
 article
115 88 In vitro and In vivo Activity of the N-7 isomeric acyclic nucleoside analogue 2242 against an acyclovir/foscarnet-resistant herpes simplex virus type 1 clinical isolate 1994
 23 S p. 83-
1 p.
 article
116 198 In Vitro and In Vivo inhibition of ortho- and paramyxovirus infection by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion 1994
 23 S p. 140-
1 p.
 article
117 123In vitro and In vivo metabolism of HOE 961 1994
 23 S p. 100-
1 p.
 article
118 78 In vitro anti-myxovirus activity of polyoxometalates 1994
 23 S p. 77-
1 p.
 article
119 94 In vitro selection of an herpes simplex virus type 1 (HSV-1) mutant resistant to the N7-isomeric acyclic nucleoside analogue 2242 1994
 23 S p. 86-
1 p.
 article
120 16 In vivo anti-herpesvirus activity of the N7-isomeric acyclic nucleoside analogue 2242 and its prodrug HOE 961 1994
 23 S p. 43-
1 p.
 article
121 45 Isolation and characterization of an HIV-1 variant with reduced sensitivity to an aminoalcohol protease inhibitor 1994
 23 S p. 59-
1 p.
 article
122 6 Kinase by-pass: A new strategy for antiviral drug discovery 1994
 23 S p. 38-
1 p.
 article
123 4 L-735, 524: An orally bioavailable human immunodeficiency virus type 1 protease inhibitor 1994
 23 S p. 37-
1 p.
 article
124 162 β-L-2′,3′-Dideoxycytidine (L-DDC) and its 5-fluoro derivative (L-FDDC) are potent inhibitors of hepatitis B virus (HBV) 1994
 23 S p. 122-
1 p.
 article
125 57 Lipophilic phosphorus prodrugs for the antiviral agent PMEA 1994
 23 S p. 65-
1 p.
 article
126 48 Local perturbation of recombinant HIV-1 reverse transcriptase by urea occurs prior to global denaturation 1994
 23 S p. 60-
1 p.
 article
127 149 Long term suppression of human immunodeficiency virus type 1 activity in vitro by guanosine/thymidine oligonucleotides (GTOs) 1994
 23 S p. 115-
1 p.
 article
128 62 Mixed infection of lymphoid cells, induced with epstain-barr virus, adenoviruses, HIV, HTLV-I as a model for screening antivirus substances 1994
 23 S p. 67-
1 p.
 article
129 139 MKC-442, a highly potent and specific inhibitor of HIV-1 1994
 23 S p. 109-
1 p.
 article
130 75 n-Docosanol cream is an effective topical treatment of recurrent herpes labialis 1994
 23 S p. 75-
1 p.
 article
131 129 New micromethod for titration of DNA viruses encoding thymidine kinase 1994
 23 S p. 103-
1 p.
 article
132 1 New opportunities for gene therapy against HIV 1994
 23 S p. 35-
1 p.
 article
133 5 Novel aminoalcohol inhibitors of HIV protease. Design, synthesis, and characterization 1994
 23 S p. 37-
1 p.
 article
134 7 Novel chiral isomeric nucleosides and nucleotides: Synthesis, enzymology and anti-HIV activity 1994
 23 S p. 38-
1 p.
 article
135 168 Novel ether lipid analogs of platelet activating factor with anti-hepatitis B virus activity 1994
 23 S p. 125-
1 p.
 article
136 21 Nucleoside derivatives of 2-mercapto-5,6-dichlorobenzimidazole: Synthesis and antiviral evaluation 1994
 23 S p. 47-
1 p.
 article
137 59 2′5′ Oligoadenylate synthetase and effects of interferon on retrovirus-producing murine lymphoma cells 1994
 23 S p. 66-
1 p.
 article
138 55 Optimization of the reverse transcriptase assay for the detection of viral burden in mice infected with rauscher murine leukemia virus 1994
 23 S p. 64-
1 p.
 article
139 Oral session II: Herpesvirus infections I 1994
 23 S p. 8-9
2 p.
 article
140 Oral session III: Herpesvirus infections II 1994
 23 S p. 16-17
2 p.
 article
141 Oral session I: Retrovirus infections I 1994
 23 S p. 7-8
2 p.
 article
142 Oral session IV: Herpesvirus infections III-retrovirus infections II 1994
 23 S p. 25-26
2 p.
 article
143 Oral session IV: Respiratory and hepatitis virus infections 1994
 23 S p. 17-18
2 p.
 article
144 Oral session VIII: Minisymposium - molecular targets/gene expression 1994
 23 S p. 34-
1 p.
 article
145 Oral session VII: Retrovirus infections III 1994
 23 S p. 26-27
2 p.
 article
146 Oral session V: Minisymposium - viral pathogenesis: Implications for antiviral therapy 1994
 23 S p. 24-
1 p.
 article
147 19 Oral vs intravenous ganciclovir (GCV) as maintenance treatment of newly diagnosed cytomegalovirus retinitis (CMVR) in AIDS 1994
 23 S p. 45-
1 p.
 article
148 18 Pharmacokinetics and bioavailability of cygalovir (BMS-180194) in asymptomatic HIV- and CMV-seropositive volunteers 1994
 23 S p. 44-
1 p.
 article
149 127 Pharmacokinetics and metabolism of systemic administration of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-Iodo-2,4(1H,3H)-pyrimidinedione (FIAU) in hartley guinea pigs 1994
 23 S p. 102-
1 p.
 article
150 159 Pharmacologically active amines as in vitro inhibitors of Junin virus 1994
 23 S p. 121-
1 p.
 article
151 124 Pharmcokinetics and therapeutic efficacy of prodrugs of N7-isomeric acyclic nucleoside analogues in animals 1994
 23 S p. 101-
1 p.
 article
152 109 Phase I trial of a new anti-cytomegalovirus agent, (s)-1[3-hydroxy-2-(phosphonyl-methoxy)propyl]cytosine (HPMPC), in HIV-infected volunteers 1994
 23 S p. 93-
1 p.
 article
153 13 Phosphonate derivatives of ganciclovir and acyclovir inhibit murine cytomegalovirus (MCMV) infections in cell culture and in mice 1994
 23 S p. 42-
1 p.
 article
154 141 Phosphorylation and subcellular distribution of HIV-1 MA protein 1994
 23 S p. 110-
1 p.
 article
155 Poster session II: Herpesvirus infections 1994
 23 S p. 18-23
6 p.
 article
156 Poster session III: Hepadnavirus, respiratory virus, and other infections 1994
 23 S p. 27-33
7 p.
 article
157 Poster session I: Retroviruses 1994
 23 S p. 10-15
6 p.
 article
158 32 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Structure activity relationships 1994
 23 S p. 52-
1 p.
 article
159 30 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Synthesis and effects of macrocyclic ring size 1994
 23 S p. 51-
1 p.
 article
160 31 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Synthesis and effects of substitution at the aromatic linker 1994
 23 S p. 52-
1 p.
 article
161 28 Potent inhibitors of HIV protease: P2 and P3 extended analogs of BMS-182,193 1994
 23 S p. 50-
1 p.
 article
162 10 Preclinical evaluation of a phosphorothioate oligonucleotide with potent antiviral activity against human cytomegalovirus 1994
 23 S p. 40-
1 p.
 article
163 100 Pretreatment with topical capsaicin (0.25%) does not prevent UV light-induced reactivation of herpes labialis (HL) 1994
 23 S p. 89-
1 p.
 article
164 154 Priming of duck hepatitis B virus DNA replication: A viral function which is refractory to inhibition by triphosphates of dideoxynucleoside analogs 1994
 23 S p. 118-
1 p.
 article
165 133 Proliferative activity of VERO cells, infected with HSV-1 variants resistant to acyclovir and phosphonoacetic acid 1994
 23 S p. 105-
1 p.
 article
166 114 Prolonged activity of penciclovir in cell culture against varicella-zoster virus 1994
 23 S p. 96-
1 p.
 article
167 191 Protective effect of bacterial preparation CM in experimental influenza infection 1994
 23 S p. 137-
1 p.
 article
168 195 Proteolysis inhibitors influence on the interactions of influenza viruses with membranes of sensitive cells 1994
 23 S p. 139-
1 p.
 article
169 64 Rapid evaluation of experimental antiretroviral therapy by quantitative competitive polymerase chain reaction (QC-PCR) assessment of HIV-1 viral load in plasma 1994
 23 S p. 68-
1 p.
 article
170 49 Recombinant human immunodeficiency virus type-1 reverse transcriptase is conformationally heterogeneous 1994
 23 S p. 61-
1 p.
 article
171 142 Replication of HIV-1 and HSV-1 in macrophages: Comparative activity of acyclic nucleoside phosphonates in the presence or absence of cytokines enhancers of virus replication 1994
 23 S p. 110-
1 p.
 article
172 205 Role of nonspecific factors of immunity in treatment of experimental arenaviral hemorrhagic fever 1994
 23 S p. 144-
1 p.
 article
173 63 Salivary inhibition of HIV: Broad antiviral activity of salivary mucin and correlation of antiviral activity with the recovery of infectious virus 1994
 23 S p. 68-
1 p.
 article
174 Satellite symposium 1994
 23 S p. 6-
1 p.
 article
175 175 Seasonal changes in metabolism in the woodchuck hepatitis virus model affect the toxicity of the antiviral nucleoside analog FEAU 1994
 23 S p. 129-
1 p.
 article
176 35 Selective activity of triciribine against HIV-1 in acutely infected CEM-T4 cells 1994
 23 S p. 54-
1 p.
 article
177 132 Selective anti HSV-1 (TK− activity of 9-(2-hydrogenphosphonyl-hydroxyethoxymethyl) guanine and its combined effects with glycyrrhisine and ribavirine 1994
 23 S p. 105-
1 p.
 article
178 189 Selective inhibition of myxovirus replication by a novel series of cholesterol-naphthalenesulfonic acid hybrid molecules 1994
 23 S p. 136-
1 p.
 article
179 33 Selective inhibition of viral dna polymerases by the triphosphates of β-L-2′,3′-dideoxycytidine (β-L-DDC) and its 5-fluoro derivative (β-L-FDDC) 1994
 23 S p. 53-
1 p.
 article
180 52 Sequence comparison of different subpopulations of proviral and ‘viral’ HIV-1 reverse transcriptase from patients on long-term AZT treatment 1994
 23 S p. 62-
1 p.
 article
181 20 Short sequences of the matrix- and the capsid-protein of the Human Immunodeficiency Virus (HIV) influence viral assembly and inhibit production of infective particles 1994
 23 S p. 46-
1 p.
 article
182 201 Single dose efficacy of 2′-fluorodGuo in the mouse and ferret influenza models 1994
 23 S p. 142-
1 p.
 article
183 Social functions 1994
 23 S p. 6-
1 p.
 article
184 138 Stereoselective synthesis of novel antiviral nucleoside analogues 1994
 23 S p. 108-
1 p.
 article
185 105 Structure-activity relationships of non-nucleoside pyrrolopyrimidine analogs active against human cytomegalovirus 1994
 23 S p. 91-
1 p.
 article
186 171 Studies on some new biological properties of isoprinosine concerning its buffer capacity 1994
 23 S p. 127-
1 p.
 article
187 126 Studies on the In Vivo synthesis and In Vitro biochemical properties of penciclovir triphosphate 1994
 23 S p. 102-
1 p.
 article
188 157 Study of chinese herbal drugs against coxsackie B1, B3, B4 virus in cell culture 1994
 23 S p. 120-
1 p.
 article
189 158 Study of chinese herbal drugs against epidemic hemorrhagic fever virus in cell culture 1994
 23 S p. 120-
1 p.
 article
190 193 Study of Chinese herbal drugs against respiratory syncytial virus in cell cultures 1994
 23 S p. 138-
1 p.
 article
191 58 Superantigen toxic syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells: Implication of a new anti-HIV-1 assay In Vitro 1994
 23 S p. 65-
1 p.
 article
192 87 Syntheses and in vivo antiviral activity of prodrugs of an N7-isomeric acyclic nucleoside analogue 1994
 23 S p. 82-
1 p.
 article
193 26 Synthesis and anti-HIV activity of isonucleosides and acyclic nucleotides related to clitocine 1994
 23 S p. 49-
1 p.
 article
194 41 Synthesis and anti-HIV-1 activity of pyrrolobenzothiadiazepines 1994
 23 S p. 57-
1 p.
 article
195 155 Synthesis and antiviral activity of novel tricyclic analogues of acyclovir and ganciclovir 1994
 23 S p. 119-
1 p.
 article
196 65 Synthesis and properties of dioxolane deoxynucleoside analogues 1994
 23 S p. 69-
1 p.
 article
197 156 Synthesis and study of structural and acyclic 6-azacytidine analogues and their substituted derivates 1994
 23 S p. 119-
1 p.
 article
198 24 Synthesis of 2-halo- and 2-aza-adenine analogues of 1,3-oxathiolane nucleoside as potential anti-HIV agents 1994
 23 S p. 48-
1 p.
 article
199 25 Synthesis of novel HEPT analogues as potential anti-HIV-1 agents 1994
 23 S p. 49-
1 p.
 article
200 8 Synthesis of novel oxathiolane and dithiolane nucleoside analogues possessing anti-HIV activity 1994
 23 S p. 39-
1 p.
 article
201 181 Synthetic peptides as analogies of the adenovirus capsid protein epitopes and possible immunotherapeutical preparations 1994
 23 S p. 132-
1 p.
 article
202 27 Systematic SAR studies of BMS-182,193, a novel inhibitor of HIV protease 1994
 23 S p. 50-
1 p.
 article
203 77 The anti-influenza virus activity of a novel neuraminidase (sialidase) inhibitor 4-guanidino Neu5Ac2en 1994
 23 S p. 77-
1 p.
 article
204 76 The development of an antirhinovirus model based on small molecule conformations 1994
 23 S p. 76-
1 p.
 article
205 128 The disposition in rats and monkeys of 2-bromo-5,6-dichloro-1-(β-D-ribofuranosyl)-benzimidazole (BDCRB) and its 2,5,6-trichloro congener (TCRB) 1994
 23 S p. 103-
1 p.
 article
206 160 The effect of some drugs on proteolytic processing of adenoviral proteins 1994
 23 S p. 121-
1 p.
 article
207 161 The effect of some nucleoside analogues on reproduction of adenoviruses 1994
 23 S p. 122-
1 p.
 article
208 The eighth international conference on antiviral research 23 – 28 April 1995 sweeny convention center sante fe, New Mexico, USA 1994
 23 S p. 151-
1 p.
 article
209 169 The inhibition of flavivirus RNA synthesis by the heteropolyanion HPA-23 and related compounds in the in vitro RNA-Dependent RNA polymerase assay 1994
 23 S p. 126-
1 p.
 article
210 202 The new adamantane derivative inhibiting DNA-viruses reproduction 1994
 23 S p. 142-
1 p.
 article
211 103 The N7-isomeric acyclic nucleoside analogue 2242 is a potent and selective inhibitor of cytomegalovirus replication 1994
 23 S p. 90-
1 p.
 article
212 206 Theoretical foundation optimal disign criteria of antiviral preparations 1994
 23 S p. 144-
1 p.
 article
213 174 Therapy of patients with chronic viral infections and prophyla xy of diseases' recurrences by vaccines 1994
 23 S p. 128-
1 p.
 article
214 110 The safety, pharmacokinetics, and anti-CMV activity of weekly HPMPC in HIV positive patients excreting CMV 1994
 23 S p. 94-
1 p.
 article
215 81 The secretion of human hepatitis B virus is inhibited by the imino sugar, N-butyldeoxynojirimycin 1994
 23 S p. 79-
1 p.
 article
216 73 The single-dose pharmacokinetics and metabolism of 882C87, a potent anti-VZV agent with a long half-life 1994
 23 S p. 74-
1 p.
 article
217 187 The study of effect of a new antiviral drug arbidol on different stages of viral reproduction 1994
 23 S p. 135-
1 p.
 article
218 125 The tolerability and pharmacokinetics of 882C87, a potent Anti-VZV agent, after 400 mg or 800 mg oncedaily dosing for 1 week in elderly volunteers 1994
 23 S p. 101-
1 p.
 article
219 2 The viral fusion protein leucine-zipper, coiled-coil domain: A target for the discovery of novel antivirals 1994
 23 S p. 36-
1 p.
 article
220 203 Toxicity of aerosolized aprotinin in animals 1994
 23 S p. 143-
1 p.
 article
221 107 Treatment of murine cytomegalovirus (MCMV) infections in cell culture and in immunocompromised mice using antibodies to MCMV alone and in combination with ganciclovir (GCV) or (S)-1-(3-hydroxy-2-phosphonylmethoxypropy1)cytosine (HPMPC) 1994
 23 S p. 92-
1 p.
 article
222 14 Treatment of viral retinitis with high dose HPMPC liposomes 1994
 23 S p. 42-
1 p.
 article
223 23 2′,3′,5′-Trideoxyuridine-5′-methylphosphonic acid: Synthesis, antiviral evaluation, and interaction of its diphosphate derivative with hiv-1 reverse transcriptase 1994
 23 S p. 48-
1 p.
 article
224 115 Uracil incorporation into thymidine kinase deficient varicella-zoster virus dna 1994
 23 S p. 96-
1 p.
 article
225 151 Use of fluorescent tracking dye PKH26 to follow the fate of HIV-infected human PBMC in SCID mice: An In Vivo model for AIDS drug development 1994
 23 S p. 116-
1 p.
 article
226 54 Uveltis in prototype AIDS vaccines using SIV 1994
 23 S p. 63-
1 p.
 article
227 44 Zidovudine (AZT)-induced down regulation of transcripts of erythropoietin receptor (Epo-R), c-fos and β-protein kinase C (PKC) in human erythroid progenitor cells (EPC): Reversal with a combination of erythropoietin and interleukin-3 1994
 23 S p. 58-
1 p.
 article
                             227 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands